United Imaging Healthcare Reports 34% Revenue Growth in 2025, Accelerates Global Expansion
Event summary
- 2025 revenue grew 34% YoY to RMB 13.8 billion, with net profit up 48% YoY to RMB 1.87 billion.
- Q1 2026 revenue increased 17% YoY to RMB 2.91 billion, with net profit up 8% YoY to RMB 0.40 billion.
- R&D investment reached RMB 2.62 billion in 2025, a 16% YoY increase, supporting the launch of the uSONIQUE ultrasound series.
- Overseas revenue grew 51% YoY to RMB 3.43 billion, with operations expanding to over 100 countries and 44 service sites globally.
The big picture
United Imaging Healthcare's strong financial performance reflects its strategic focus on innovation and global expansion, particularly in high-growth emerging markets. The company's ability to secure regulatory approvals for advanced technologies positions it as a key player in the high-end medical equipment sector, competing directly with established Western manufacturers.
What we're watching
- Regulatory Momentum
- The pace at which United Imaging Healthcare secures additional regulatory approvals, particularly for its radiotherapy systems in Europe.
- Emerging Market Growth
- Whether the company can sustain its 80% YoY growth rate in emerging markets like South Asia and MENA.
- Innovation Leadership
- How the commercialization of AI-enabled medical devices will impact market share against competitors.
Our editorial coverage:
Related topics